GLEIF logo

GLEIF-accredited LEI Issuer. #1 LEI Issuer Globally.

RapidLEI logo

Public LEI record · Global LEI Index

Canada

Abattis Bioceuticals Corp.

970 Burrard Street, Suit 224, Vancouver, V6Z 2R4, CA

Legal Entity Identifier 5493000GEXZZJ997G829
Entity status
Active
LEI status
Lapsed
Policy conformity
Non-conforming
Reference data
Register-verified
Next renewal
10 Jan 2019
LEI Issuer
EQS
Reactivate and transfer this LEI Reactivation keeps the same identifier. A transfer changes which LEI Issuer manages the record; the LEI code and its reference data do not change.

Record snapshot

The Legal Entity Identifier for Abattis Bioceuticals Corp. is 5493000GEXZZJ997G829. It has lapsed and has not been renewed.

Abattis Bioceuticals Corp. is an INCORPORATED / INCORPOREE formed in Canada, registered as 0545758 with Corporate Registry (Province of British Columbia), Canada. The LEI was registered on 11 Jan 2018. At its last validation on 8 Aug 2023, all of its Level 1 reference data was confirmed against Corporate Registry (Province of British Columbia), Canada. It reports no parent, on the grounds that it is controlled by individuals, who cannot hold an LEI. EQS maintains the record.

A lapsed LEI is publicly visible and may block derivatives reporting, client onboarding and settlement until it is renewed. Reactivation keeps the same identifier.

Record lifecycle

Lapsed since 9 Aug 2023.

First LEI registered on 11 Jan 2018. It lapsed on 9 Aug 2023 and has not been renewed in the 3 years since.

11 Jan 2018 LEI issued 10 Jan 2019 Renewal was due

Registered entity Level 1 data

Legal name
Abattis Bioceuticals Corp.
Legal form
INCORPORATED / INCORPOREE 8888
Former legal name
Abattis Biologix Corporation
Jurisdiction
Canada CA
Registration
Registered at Corporate Registry (Province of British Columbia), Canada RA000074. Registration number 0545758
Legal address
970 Burrard Street, Suit 224, Vancouver, V6Z 2R4, CA
Connected identifiers
S&P Capital IQ4049120 Other identifiers recorded against this LEI.
Securities
US00258G2021 1 ISIN is mapped to this LEI in the ANNA and GLEIF ISIN-to-LEI file.

What this record’s status means

Reference data
Register-verified GLEIF records this as fully corroborated. At its last validation, all of the entity's Level 1 reference data was verified against an authoritative public source.
Policy conformity
Non-conforming The registration has lapsed. Renewing it clears the flag.

Changes to this record

  1. Registration status changed from Pending archival to Lapsed.

Show 9 earlier changes

  1. Renewed. The next renewal date is now 10 Jan 2019.

  2. Management of this LEI transferred from GMEI Utility a service of BED B.V. to EQS.

  3. Registration status changed from Pending transfer to Pending archival.

  4. Registration status changed from Lapsed to Pending transfer.

  5. Legal jurisdiction recorded as Canada.

  6. Registration status changed from Issued to Lapsed.

  7. Legal jurisdiction changed.

  8. Renewed. The next renewal date is now 10 Jan 2019.

  9. The LEI was registered and first published to the Global LEI Index.

Ownership Level 2 data

  1. Ultimate parent
    Owned by individuals Reported exception Natural persons cannot hold an LEI
  2. Direct parent
    Owned by individuals Reported exception Natural persons cannot hold an LEI
  3. This entity

    Abattis Bioceuticals Corp.

    CA · 5493000GEXZZJ997G829

    Active

  4. Below
    0 Direct subsidiaries
    0 Ultimate subsidiaries

    The chain ends here. No other entity reports Abattis Bioceuticals Corp. as its parent, so the count is a stated zero rather than data still to arrive.

Level 2 data records who consolidates this entity. A reported relationship, or a reported reason for the absence of one, both satisfy the standard. Only a record carrying neither is incomplete.

Where this data comes from

Source registry

Corporate Registry (Province of British Columbia), Canada

Validated against

Corporate Registry (Province of British Columbia), Canada

Maintained by

EQS

Published in

The GLEIF Global LEI Index. This record last updated 8 Aug 2023

Abattis Bioceuticals Corp.

This LEI has lapsed. Publishing it signals reference data that has not been revalidated. Renew it first. Reactivate and transfer this LEI

Add this schema to your homepage. Replace the two example.com values with your own homepage address before publishing.

How to use this

Reference data from the GLEIF Global LEI Index, as published on 8 Aug 2023.